内容へ

鎌状赤血球症

クリーゼの回避

胎児ヘモグロビンの薬理学的誘導

Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (新しいタブで開く)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

出典‎: Ann Intern Med 2008;148(12):939-55.

インデックス‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (新しいタブで開く)

Hydroxyurea for the treatment of sickle cell anemia. (新しいタブで開く)

Platt OS.

出典‎: N Engl J Med 2008;358(13):1362-9.

インデックス‎: PubMed 18367739

DOI‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (新しいタブで開く)

Clinical effectiveness of decitabine in severe sickle cell disease. (新しいタブで開く)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

出典‎: Br J Haematol 2008;141(1):126-9.

インデックス‎: PubMed 18324975

DOI‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (新しいタブで開く)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (新しいタブで開く)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

出典‎: Blood 2010;115(12):2354-63.

インデックス‎: PubMed 19903897

DOI‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (新しいタブで開く)

感染などの合併症の予防

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (新しいタブで開く)

Hirst C, Owusu-Ofori S.

出典‎: Cochrane Database Syst Rev 2012;(9):CD003427.

インデックス‎: PubMed 22972063

DOI‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (新しいタブで開く)

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. (新しいタブで開く)

Howard J, Ataga KI, Brown RC, Achebe M, Nduba V, El-Beshlawy A, Hassab H, Agodoa I, Tonda M, Gray S, Lehrer-Graiwer J, Vichinsky E

出典‎: Lancet Haematol 2021;8(5):e323-33.

インデックス‎: PubMed 33838113

DOI‎: 10.1016/S2352-3026(21)00059-4

https://www.ncbi.nlm.nih.gov/pubmed/33838113 (新しいタブで開く)

Sickle cell disease. (新しいタブで開く)

Meremikwu MM, Okomo U.

出典‎: BMJ Clin Evid 2011;02:2402.

インデックス‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (新しいタブで開く)

A phase 3 trial of l-glutamine in sickle cell disease. (新しいタブで開く)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

出典‎: N Engl J Med 2018;379(3):226-35.

インデックス‎: PubMed 30021096

DOI‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (新しいタブで開く)

Malaria chemoprophylaxis in sickle cell disease. (新しいタブで開く)

Oniyangi O, Omari AA.

出典‎: Cochrane Database Syst Rev 2006;(4):CD003489.

インデックス‎: PubMed 17054173

DOI‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (新しいタブで開く)